Live Chat

I CFD sono strumenti complessi e presentano un alto rischio di perdere soldi rapidamente a causa della leva finanziaria. Il 76,3% dei conti di clienti al dettaglio perde denaro facendo trading con i CFD con questo fornitore. Devi verificare se comprendi pienamente come funzionano i CFD e se puoi permetterti di correre il rischio elevato di perdere i tuoi soldi.

Close

Fai trading su Vir Biotechnology VIR

Grafico live di VirBiotechnology

Percezioni e opinioni

Weekly Search
Weekly
Daily
date Chiudi change variazione % Apertura Massimo Minimo

Markets.com news

French election results to drive European markets
markets.com Support Team 2024 Jul 04, 21:00

La prossima settimana: I risultati delle elezioni francesi saranno chiave per i mercati europei

Forex Indici
Macron calls snap election, riles markets
markets.com Support Team 2024 Jun 29, 21:00

La prossima settimana: La Francia scatenerà una crisi dell'euro?

CPI
Businessman pointing hologram online banking icon.
markets.com Support Team 2024 Jun 20, 16:00

La prossima settimana: Una carrellata di dati e uno sguardo all’inflazione

Forex Indici
RBA, SNB, Bank of England rate decisions due next week
markets.com Support Team 2024 Jun 13, 21:00

La prossima settimana: RBA e Bank of England - status quo o cambio all’orizzonte?

Forex Indici

Informazioni

Spread

0.05

Spread (%)

0.6623 %

Leva

1:5

Interesse overnight acquisto

-0.0597 %

Interesse overnight vendita

-0.0292 %

Valuta

USD

Orari di trading

Markets closed

Martedì

14:31 - 20:59

Lunedì

14:31-20:59

Mercoledì

14:31-20:59

Giovedi

14:31-20:59

Venerdì

14:31-20:59

Conto economico

Apertura

---

Chiusura precedente

---

Massimo/Minimo di 52 settimane

--- – ---

Capitalizzazione di mercato

1010864832

Azioni in circolazione

137720000

Data delle trimestrali (prossima)

0000-00-00

instr__dividend_date

instr__ex_dividend_date

instr__forward_annual_dividend_rate

0

instr__forward_annual_dividend_yield

0

EPS

-3.93

Azioni in circolazione

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., an immunology company, develops therapeutic products to treat and prevent serious infectious diseases. Its clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; collaboration with WuXi Biologics (Hong Kong) Limited and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. The company was incorporated in 2016 and is headquartered in San Francisco, California.

Scopri di più su questo strumento

Strumenti correlati
Trustpilot
Live Chat